|
|
|
Volumn 5, Issue 2, 1996, Pages 71-77
|
|
Antihypertensive efficacy of the angiotensin II AT1-receptor antagonist losartan: Results of a randomized, double-blind, placebo-controlled, parallel-group trial using 24-hour blood pressure monitoring
|
|
Author keywords
Ambulatory blood pressure monitoring; Angiotensin H receptor antagonist; Angiotensin II; Essential hypertension; Losartan; Randomized blind trial
|
|
Indexed keywords
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
HYDROCHLOROTHIAZIDE;
LOSARTAN;
ANGIOTENSIN RECEPTOR;
BIPHENYL DERIVATIVE;
IMIDAZOLE DERIVATIVE;
TETRAZOLE DERIVATIVE;
ADULT;
BLOOD PRESSURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
HEART RATE;
HOLTER MONITORING;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ARTICLE;
BLOOD PRESSURE MONITORING;
DRUG ANTAGONISM;
DRUG EFFECT;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
BIPHENYL COMPOUNDS;
BLOOD PRESSURE;
BLOOD PRESSURE MONITORING, AMBULATORY;
DOUBLE-BLIND METHOD;
HUMANS;
HYPERTENSION;
IMIDAZOLES;
LOSARTAN;
RECEPTORS, ANGIOTENSIN;
TETRAZOLES;
TREATMENT OUTCOME;
|
|
EID: 0029817681
PISSN: 08038023
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (15)
|
|
References (0)
|
